VACUNACIÓN CDC 2014

1. TABLE. Contraindications and precautions to commonly used vaccines in adults: United States, 2014
‚
Vaccine
Contraindications
Precautions
,QÀXHQ]D LQDFWLYDWHG YDFFLQH
,,9

2. 2
6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

3. DIWHU SUHYLRXV GRVH RI DQ
,,9 RU /$,9 RU WR D YDFFLQH FRPSRQHQW LQFOXGLQJ HJJ SURWHLQ
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
+LVWRU RI *XLOODLQ%DUUp 6QGURPH ZLWKLQ ZHHNV RI SUHYLRXV LQÀXHQ]D
vaccination.
Persons who experience only hives with exposure to eggs may receive RIV
LI DJH HDUV

4. RU ZLWK DGGLWLRQDO VDIHW SUHFDXWLRQV ,,92
,QÀXHQ]D UHFRPELQDQW 5,9

5. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

6. DIWHU SUHYLRXV GRVH RI 5,9
or to a vaccine component. RIV does not contain any egg protein.2
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
+LVWRU RI *XLOODLQ%DUUp 6QGURPH ZLWKLQ ZHHNV RI SUHYLRXV LQÀXHQ]D
vaccination.
,QÀXHQ]D OLYH DWWHQXDWHG
/$,9

7. 2,3
6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

8. DIWHU SUHYLRXV GRVH RI DQ
,,9 RU /$,9 RU WR D YDFFLQH FRPSRQHQW LQFOXGLQJ HJJ SURWHLQ
RQGLWLRQV IRU ZKLFK WKH $GYLVRU RPPLWWHH RQ ,PPXQL]DWLRQ
3UDFWLFHV $,3

9. UHFRPPHQGV DJDLQVW XVH EXW ZKLFK DUH QRW
FRQWUDLQGLFDWLRQV LQ YDFFLQH SDFNDJH LQVHUW LPPXQH VXSSUHVVLRQ
FHUWDLQ FKURQLF PHGLFDO FRQGLWLRQV VXFK DV DVWKPD GLDEHWHV KHDUW RU
NLGQH GLVHDVH

10. DQG SUHJQDQF2,3
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
+LVWRU RI *XLOODLQ%DUUp 6QGURPH ZLWKLQ ZHHNV RI SUHYLRXV LQÀXHQ]D
vaccination.
5HFHLSW RI VSHFL¿F DQWLYLUDOV LH DPDQWDGLQH ULPDQWDGLQH ]DQDPLYLU RU
RVHOWDPLYLU

11. ZLWKLQ KRXUV EHIRUH YDFFLQDWLRQ $YRLG XVH RI WKHVH DQWLYLUDO
GUXJV IRU GDV DIWHU YDFFLQDWLRQ
Tetanus, diphtheria, pertussis
7GDS

12. WHWDQXV GLSKWKHULD 7G

13. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

14. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
)RU SHUWXVVLVFRQWDLQLQJ YDFFLQHV HQFHSKDORSDWK HJ FRPD
GHFUHDVHG OHYHO RI FRQVFLRXVQHVV RU SURORQJHG VHL]XUHV

15. QRW DWWULEXWDEOH WR DQRWKHU LGHQWL¿DEOH FDXVH ZLWKLQ GDV RI
administration of a previous dose of Tdap or diphtheria and tetanus
WR[RLGV DQG SHUWXVVLV '73

16. RU GLSKWKHULD DQG WHWDQXV WR[RLGV DQG
DFHOOXODU SHUWXVVLV '7D3

17. YDFFLQH
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
*XLOODLQ%DUUp 6QGURPH ZLWKLQ ZHHNV DIWHU D SUHYLRXV GRVH RI WHWDQXV WR[RLG±
containing vaccine.
+LVWRU RI $UWKXVWSH KSHUVHQVLWLYLW UHDFWLRQV DIWHU D SUHYLRXV GRVH RI WHWDQXV
RU GLSKWKHULD WR[RLG±FRQWDLQLQJ YDFFLQH GHIHU YDFFLQDWLRQ XQWLO DW OHDVW HDUV
have elapsed since the last tetanus toxoid-containing vaccine.
)RU SHUWXVVLVFRQWDLQLQJ YDFFLQHV SURJUHVVLYH RU XQVWDEOH QHXURORJLF GLVRUGHU
XQFRQWUROOHG VHL]XUHV RU SURJUHVVLYH HQFHSKDORSDWK XQWLO D WUHDWPHQW UHJLPHQ
KDV EHHQ HVWDEOLVKHG DQG WKH FRQGLWLRQ KDV VWDELOL]HG
Varicella3
6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

18. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
.QRZQ VHYHUH LPPXQRGH¿FLHQF HJ IURP KHPDWRORJLF DQG VROLG
WXPRUV UHFHLSW RI FKHPRWKHUDS FRQJHQLWDO LPPXQRGH¿FLHQF
or long-term immunosuppressive therapy or patients with
KXPDQ LPPXQRGH¿FLHQF YLUXV +,9

19. LQIHFWLRQ ZKR DUH VHYHUHO
LPPXQRFRPSURPLVHG

20. Pregnancy.
5HFHQW ZLWKLQ PRQWKV

21. UHFHLSW RI DQWLERGFRQWDLQLQJ EORRG SURGXFW
VSHFL¿F LQWHUYDO GHSHQGV RQ SURGXFW

22. 0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
5HFHLSW RI VSHFL¿F DQWLYLUDOV LH DFFORYLU IDPFLFORYLU RU YDODFFORYLU

23. KRXUV EHIRUH YDFFLQDWLRQ DYRLG XVH RI WKHVH DQWLYLUDO GUXJV IRU GDV DIWHU
vaccination.
+XPDQ SDSLOORPDYLUXV +39

24. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

25. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
Pregnancy.
Zoster3
6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

26. WR D YDFFLQH FRPSRQHQW
.QRZQ VHYHUH LPPXQRGH¿FLHQF HJ IURP KHPDWRORJLF DQG VROLG
tumors, receipt of chemotherapy, or long-term immunosuppressive
therapy RU SDWLHQWV ZLWK +,9 LQIHFWLRQ ZKR DUH VHYHUHO
LPPXQRFRPSURPLVHG

27. Pregnancy.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
5HFHLSW RI VSHFL¿F DQWLYLUDOV LH DFFORYLU IDPFLFORYLU RU YDODFFORYLU

28. KRXUV EHIRUH YDFFLQDWLRQ DYRLG XVH RI WKHVH DQWLYLUDO GUXJV IRU GDV DIWHU
vaccination.
0HDVOHV PXPSV UXEHOOD
005

29. 3
6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

30. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
.QRZQ VHYHUH LPPXQRGH¿FLHQF HJ IURP KHPDWRORJLF DQG VROLG
WXPRUV UHFHLSW RI FKHPRWKHUDS FRQJHQLWDO LPPXQRGH¿FLHQF RU
long-term immunosuppressive therapy RU SDWLHQWV ZLWK +,9 LQIHFWLRQ
ZKR DUH VHYHUHO LPPXQRFRPSURPLVHG

31. Pregnancy.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
5HFHQW ZLWKLQ PRQWKV

32. UHFHLSW RI DQWLERGFRQWDLQLQJ EORRG SURGXFW
VSHFL¿F LQWHUYDO GHSHQGV RQ SURGXFW

33. +LVWRU RI WKURPERFWRSHQLD RU WKURPERFWRSHQLF SXUSXUD
1HHG IRU WXEHUFXOLQ VNLQ WHVWLQJ6
Pneumococcal conjugate
39

34. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

35. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component, including to any vaccine containing diphtheria
toxoid.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
Pneumococcal polysaccharide
3369

36. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

37. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
0HQLQJRFRFFDO FRQMXJDWH
0HQ$:

38. PHQLQJRFRFFDO
SROVDFFKDULGH 0369

39. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

40. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
+HSDWLWLV $ +HS$

41. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

42. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
+HSDWLWLV % +HS%

43. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

44. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
+DHPRSKLOXV LQÀXHQ]DH Type
E +LE

45. 6HYHUH DOOHUJLF UHDFWLRQ HJ DQDSKOD[LV

46. DIWHU D SUHYLRXV GRVH RU WR
a vaccine component.
0RGHUDWH RU VHYHUH DFXWH LOOQHVV ZLWK RU ZLWKRXW IHYHU
9DFFLQH SDFNDJH LQVHUWV DQG WKH IXOO $,3 UHFRPPHQGDWLRQV IRU WKHVH YDFFLQHV VKRXOG EH FRQVXOWHG IRU DGGLWLRQDO LQIRUPDWLRQ RQ YDFFLQHUHODWHG FRQWUDLQGLFDWLRQV DQG SUHFDXWLRQV DQG IRU PRUH
LQIRUPDWLRQ RQ YDFFLQH H[FLSLHQWV (YHQWV RU FRQGLWLRQV OLVWHG DV SUHFDXWLRQV VKRXOG EH UHYLHZHG FDUHIXOO %HQH¿WV RI DQG ULVNV IRU DGPLQLVWHULQJ D VSHFL¿F YDFFLQH WR D SHUVRQ XQGHU WKHVH
FLUFXPVWDQFHV VKRXOG EH FRQVLGHUHG ,I WKH ULVN IURP WKH YDFFLQH LV EHOLHYHG WR RXWZHLJK WKH EHQH¿W WKH YDFFLQH VKRXOG QRW EH DGPLQLVWHUHG ,I WKH EHQH¿W RI YDFFLQDWLRQ LV EHOLHYHG WR RXWZHLJK WKH
ULVN WKH YDFFLQH VKRXOG EH DGPLQLVWHUHG $ FRQWUDLQGLFDWLRQ LV D FRQGLWLRQ LQ D UHFLSLHQW WKDW LQFUHDVHV WKH FKDQFH RI D VHULRXV DGYHUVH UHDFWLRQ 7KHUHIRUH D YDFFLQH VKRXOG QRW EH DGPLQLVWHUHG
when a contraindication is present.
2. )RU PRUH LQIRUPDWLRQ RQ XVH RI LQÀXHQ]D YDFFLQHV DPRQJ SHUVRQV ZLWK HJJ DOOHUJLHV DQG D FRPSOHWH OLVW RI FRQGLWLRQV WKDW ' FRQVLGHUV WR EH UHDVRQV WR DYRLG UHFHLYLQJ /$,9 VHH ' 3UHYHQWLRQ
DQG FRQWURO RI VHDVRQDO LQÀXHQ]D ZLWK YDFFLQHV UHFRPPHQGDWLRQV RI WKH $GYLVRU RPPLWWHH RQ ,PPXQL]DWLRQ 3UDFWLFHV $,3

47. ² 8QLWHG 6WDWHV ± MMWR 55

48. $YDLODEOH DW
KWWSZZZFGFJRYPPZUSUHYLHZPPZUKWPOUUDKWP.
3. /$,9 005 YDULFHOOD RU ]RVWHU YDFFLQHV FDQ EH DGPLQLVWHUHG RQ WKH VDPH GD ,I QRW DGPLQLVWHUHG RQ WKH VDPH GD OLYH YDFFLQHV VKRXOG EH VHSDUDWHG E DW OHDVW GDV
Immunosuppressive steroid dose is considered to be ZHHNV RI GDLO UHFHLSW RI PJ RI SUHGQLVRQH RU WKH HTXLYDOHQW 9DFFLQDWLRQ VKRXOG EH GHIHUUHG IRU DW OHDVW PRQWK DIWHU GLVFRQWLQXDWLRQ RI
VXFK WKHUDS 3URYLGHUV VKRXOG FRQVXOW $,3 UHFRPPHQGDWLRQV IRU FRPSOHWH LQIRUPDWLRQ RQ WKH XVH RI VSHFL¿F OLYH YDFFLQHV DPRQJ SHUVRQV RQ LPPXQHVXSSUHVVLQJ PHGLFDWLRQV RU ZLWK LPPXQH
suppression because of other reasons.
9DFFLQH VKRXOG EH GHIHUUHG IRU WKH DSSURSULDWH LQWHUYDO LI UHSODFHPHQW LPPXQH JOREXOLQ SURGXFWV DUH EHLQJ DGPLQLVWHUHG 6HH ' *HQHUDO UHFRPPHQGDWLRQV RQ LPPXQL]DWLRQ UHFRPPHQGDWLRQV
RI WKH $GYLVRU RPPLWWHH RQ ,PPXQL]DWLRQ 3UDFWLFHV $,3

49. MMWR 1R 55

50. $YDLODEOH DW www.cdc.gov/vaccines/hcp/acip-recs/index.html.
6. 0HDVOHV YDFFLQDWLRQ PLJKW VXSSUHVV WXEHUFXOLQ UHDFWLYLW WHPSRUDULO 0HDVOHVFRQWDLQLQJ YDFFLQH PD EH DGPLQLVWHUHG RQ WKH VDPH GD DV WXEHUFXOLQ VNLQ WHVWLQJ ,I WHVWLQJ FDQQRW EH SHUIRUPHG
XQWLO DIWHU WKH GD RI 005 YDFFLQDWLRQ WKH WHVW VKRXOG EH SRVWSRQHG IRU DW OHDVW ZHHNV DIWHU WKH YDFFLQDWLRQ ,I DQ XUJHQW QHHG H[LVWV WR VNLQ WHVW GR VR ZLWK WKH XQGHUVWDQGLQJ WKDW UHDFWLYLW
might be reduced by the vaccine.
$GDSWHG IURP ' 7DEOH RQWUDLQGLFDWLRQV DQG SUHFDXWLRQV WR FRPPRQO XVHG YDFFLQHV *HQHUDO UHFRPPHQGDWLRQV RQ LPPXQL]DWLRQ UHFRPPHQGDWLRQV RI WKH $GYLVRU RPPLWWHH RQ
,PPXQL]DWLRQ 3UDFWLFHV MMWR 1R 55

51. ± DQG IURP $WNLQVRQ : :ROIH 6 +DPERUVN - HGV $SSHQGL[ $ (SLGHPLRORJ DQG SUHYHQWLRQ RI YDFFLQH SUHYHQWDEOH GLVHDVHV WK HG
:DVKLQJWRQ ' 3XEOLF +HDOWK )RXQGDWLRQ $YDLODEOH DW ZZZFGFJRYYDFFLQHVSXEVSLQNERRNLQGH[KWPO.
‚ 5HJDUGLQJ ODWH[ DOOHUJ FRQVXOW WKH SDFNDJH LQVHUW IRU DQ YDFFLQH DGPLQLVWHUHG
U.S. Department of Health and Human Services
Centers for Disease and Prevention